AzTrials
AzTrials

Clinician-in-the-loopNCT07187050

LLM-Assisted vs Manual Writing for Clinical Documentation: Effects on Time and Quality

A study testing Template-Based LLM Assistant and Manual Writing in people with Clinician-in-the-loop and Clinical Documentation, run by Kyoto University, Graduate School of Medicine at 1 site in Japan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn whether an LLM-assisted writing workflow can reduce the time to complete hospital discharge summaries and discharge referrals and maintain or improve document quality compared with writing from scratch by clinicians. Read more about this study

Who is it for?
Any age
What is being tested?
Template-Based LLM Assistant and Manual Writing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
21 participants
Where
1 siteJapan
Study dates
18 Feb 2025to 16 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Ophthalmologists at Kyoto University Hospital
  • Junior residents, senior residents, graduate students, board-certified ophthalmologists
  • Physicians who confirm that they do not routinely use CocktailAI for clinical documentation and provide informed consent after receiving an explanation of the study.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Japan1 site
  • Department of Ophthalmology and Visual Sciences Kyoto University Graduate School of Medicine 54 Shogoin, Kawahara, Sakyo

    Kyoto, 606-8507

Other trials in Japan

About this study

Official title: Evaluating an LLM-Assisted Workflow for Clinical Documentation: A Pilot Randomized Controlled Trial on Time and Quality

The goal of this clinical trial is to learn whether an LLM-assisted writing workflow can reduce the time to complete hospital discharge summaries and discharge referrals and maintain or improve document quality compared with writing from scratch by clinicians. The study used six simulated patient records (no real patient data).

The main questions it aims to answer are:

Read more
  • Does the LLM-assisted writing workflow reduce the time needed to complete each document compared with manual writing?
  • Does the LLM-assisted writing workflow improve (or at least maintain) document quality compared with manual writing, as rated by blinded experts?

Researchers will compare LLM-assisted versus manual writing to see if the LLM-assisted approach is faster and has equal or better quality. LLM-only drafts (unedited first drafts) will be evaluated as a separate third group to understand the baseline quality of LLM output without clinician edits.

Participants will create two documents-a discharge summary and a discharge referral-for each of six simulated cases. Those assigned to CocktailAI \& Modification group will use an LLM assistant (called CocktailAI) to generate a first draft for each document and then review and edit it to finalize; those assigned to the control group will write each document from scratch without LLM assistance.

Being tested
Template-Based LLM Assistant, Manual Writing
Keywords
clinician-in-the-loop, Large Language Model, Clinical Documentation, Electronic Health Record

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Template-Based LLM AssistantOther

    This study uses CocktailAI, a template-based LLM assistant co-developed by the Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, and Fitting Cloud Inc. (Kyoto, Japan). It is designed to extract relevant information from EHRs using LLMs and embed the extracted content into predefined templates. In this trial, the inputs are six simulated patient records (no real patient data). Text generation uses Gemini-2.0-flash-lite. Templates for discharge summaries and discharge referrals are pre-defined by a team member.

  • Manual WritingOther

    The same document templates are provided; however, all LLM instruction prompts are removed in advance. Clinicians manually write the documents, following the template structure, for each of the six simulated cases.

Study groups in NCT07187050
Study groupRoleWhat they receive
CocktailAI & Modification armExperimentalParticipants log into the study web application using a unique ID and their name. For each simulated patient case, they press "Start" to unlock the case record and initiate timing. After viewing the patient information, clinicians use CocktailAI to generate a first draft of the discharge summary. They then review and edit the draft and submit the final document by pressing "Submit." For the discharge referral of the same case, clinicians follow the same procedure. Copy-and-paste from the case record is permitted. This sequence is repeated for six simulated cases.
Receives: Other: Template-Based LLM Assistant
Control armActive comparatorParticipants log into the study web application using a unique ID and their name. For each simulated patient case, they press "Start" to unlock the case record and initiate timing. After viewing the patient information, clinicians write the discharge summary from scratch and submit the document by pressing "Submit." They then write the discharge referral for the same case from scratch and submit it. Copy-and-paste from the case record is permitted. This sequence is repeated for six simulated cases.
Receives: Other: Manual Writing
CocktailAI armActive comparatorThe LLM assistant generates drafts of discharge summaries and discharge referrals directly from the simulated patient records, with no clinician review or edits. These drafts are the unedited first drafts produced in the CocktailAI \& Modification arm (captured before any clinician edits) and are included as a separate group.
Receives: Other: Template-Based LLM Assistant

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Average time spent creating each document

    In the CocktailAI \& Modification group and the Control group, the time spent creating documents is measured in seconds. In the CocktailAI group, the time required for document generation is measured in seconds.

    Measured: On one study day within 2 weeks after enrollment

Secondary outcomes (1)
  1. Document quality assessment

    Blinded to group allocation, ophthalmology experts evaluate the documents using pre-specified criteria defined before study initiation. These criteria are developed based on six domains: Medical Accuracy, Language, Conciseness, Presence of Hallucinations, Validity for Clinical Use, and Possibility of Harm. Most domains are assessed on a three-point scale, whereas Presence of Hallucinations is evaluated dichotomously (present or absent). In addition to these domain-specific ratings, experts provide a subjective overall score on a 10-point scale (with higher scores indicating better quality) and are asked to guess which study group the document belongs to.

    Measured: On one study day within 2 weeks after enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Sep 2025
  2. Study start18 Feb 2025
  3. Primary completion14 Mar 2025
  4. Study completion16 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a prospective, randomized, open-label, blinded-endpoint (PROBE) trial.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07187050
Sponsor's protocol ID
clinician-in-the-loop_workflow
Status last verified
Sep 2025
First submitted
2 Sep 2025
Last updated
22 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Takayama T, Sado K, Suda K, Tamura H, Ueda-Arakawa N, Ishihara K, Ueda Y, Okamoto K, Santos LHO, Oshika T, Kuroda T, Tsujikawa A, Miyake M. Evaluating an LLM-assisted workflow for clinical documentation: A pilot randomized controlled trial on time and quality. PLOS Digit Health. 2026 Oct 26;5(10):e0001799. doi: 10.1371/journal.pdig.0001799. eCollection 2026 Oct.

    PubMed 42932273

Questions about this trial

What is this clinical trial studying?

A study testing Template-Based LLM Assistant and Manual Writing in people with Clinician-in-the-loop and Clinical Documentation, run by Kyoto University, Graduate School of Medicine at 1 site in Japan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Japan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Average time spent creating each document (time frame: On one study day within 2 weeks after enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07187050, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in